Skip to content

Clinical trials

Phase 2 Esophageal Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 2 Country / region: Taiwan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20072
20081
20091
20161
20192
20201
20212
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status5
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital9
AstraZeneca1
BeiGene1
Daiichi Sankyo1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
PharmaEngine1
PhytoHealth Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms16
Stomach Neoplasms4
Esophageal Squamous Cell Carcinoma3
Adenocarcinoma2
Carcinoma, Non-Small-Cell Lung2
Cholangiocarcinoma2
Endometrial Neoplasms2
Neoplasm Metastasis2
Neoplasms2
Ovarian Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.